SOR decreases tumor cell proliferation and angiogenesis by inhibiting vascular endothelial growth factor receptor (VEGFR), fibroblast growth factor receptor, platelet-derived growth factor receptor, and Ras/Raf/MEK signaling cascade [14]. This evidence concerns the gene KDR and neoplasm.